http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1997913-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ff529b7e4a6c75b7dc55d7cccd348939 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
filingDate | 2003-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac2f3d5a29a930d76b880f2ff8bca2ce http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1f23257be298cedbdf3c865053ed17b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2cad2c6d0746a2d5f33d01307a9634a3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc6dbeb3a60220628f40b3db0f3a72d5 |
publicationDate | 2008-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-1997913-A1 |
titleOfInvention | Human obesity susceptibility gene and uses thereof |
abstract | The present invention discloses the identification of a human obesity susceptibility gene, which can be used for the diagnosis, prevention and treatment of obesity and related disorders, as well as for the screening of therapeutically active drugs. The invention more specifically discloses that the PPYR1 gene on chromosome 10 and certain alleles thereof are related to susceptibility to obesity and represent novel targets for therapeutic intervention. The present invention relates to particular mutations in the PPYR1 gene and expression products, as well as to diagnostic tools and kits based on these mutations. The invention can be used in the diagnosis of predisposition to, detection, prevention and/or treatment of coronary heart disease and metabolic disorders, including hypoalphalipoproteinemia, familial combined hyperlipidemia, insulin resistant syndrome X or multiple metabolic disorder, coronary artery disease, diabetes and dyslipidemic hypertension. |
priorityDate | 2002-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 272.